Cardiovascular Systems Alpha and Beta Analysis
| CSIIDelisted Stock | USD 20.00 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cardiovascular Systems. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cardiovascular Systems over a specified time horizon. Remember, high Cardiovascular Systems' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cardiovascular Systems' market risk premium analysis include:
Beta (1.11) | Alpha 0.85 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Cardiovascular |
Cardiovascular Systems Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cardiovascular Systems market risk premium is the additional return an investor will receive from holding Cardiovascular Systems long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cardiovascular Systems. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cardiovascular Systems' performance over market.| α | 0.85 | β | -1.11 |
Cardiovascular Systems Fundamentals Vs Peers
Comparing Cardiovascular Systems' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cardiovascular Systems' direct or indirect competition across all of the common fundamentals between Cardiovascular Systems and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cardiovascular Systems or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cardiovascular Systems' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cardiovascular Systems by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cardiovascular Systems to competition |
| Fundamentals | Cardiovascular Systems | Peer Average |
| Return On Equity | -0.15 | -0.31 |
| Return On Asset | -0.0756 | -0.14 |
| Profit Margin | (0.16) % | (1.27) % |
| Operating Margin | (0.16) % | (5.51) % |
| Current Valuation | 466.13 M | 16.62 B |
| Shares Outstanding | 42.2 M | 571.82 M |
| Shares Owned By Insiders | 3.22 % | 10.09 % |
Cardiovascular Systems Opportunities
Cardiovascular Systems Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Abbott to acquire Cardiovascular Systems for 890 mln | 02/08/2023 |
2 | Cardiovascular Systems Releases Quarterly Earnings Results, Misses Expectations By 0.05 EPS | 02/09/2023 |
3 | SHAREHOLDER ALERT Weiss Law Reminds INDT, TA, CSII, and ... - Bloomberg | 02/27/2023 |
4 | SHAREHOLDER ALERT Weiss Law Reminds INDT, TA, CSII, and ... - Longview News-Journal | 03/06/2023 |
5 | HEART TEST LABORATORIES, INC. Managements Discussion and Analysis of Financial Condition and Results of Operations. - Marketscreener.com | 03/16/2023 |
6 | Merit Medicals New Launch to Boost its Product Suite - Nasdaq | 03/21/2023 |
7 | Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial | 04/03/2023 |
8 | Cardiovascular Systems Share Price Passes Above 200 Day Moving Average of 15.65 | 04/12/2023 |
9 | Cardiovascular Systems, Inc.s Subdued PS Might Signal An Opportunity | 04/19/2023 |
10 | HDL Therapeutics makes deal to go public via Swiftmerge SPAC - Endpoints News | 04/24/2023 |
11 | Merit Medical Tops Q1 Earnings Estimates, Ups FY23 View - Nasdaq | 04/28/2023 |
About Cardiovascular Systems Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cardiovascular or other delisted stocks. Alpha measures the amount that position in Cardiovascular Systems has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Cardiovascular Systems Upcoming Company Events
As portrayed in its financial statements, the presentation of Cardiovascular Systems' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cardiovascular Systems' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Cardiovascular Systems' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Cardiovascular Systems. Please utilize our Beneish M Score to check the likelihood of Cardiovascular Systems' management manipulating its earnings.
| 3rd of May 2023 Upcoming Quarterly Report | View | |
| 1st of August 2023 Next Financial Report | View | |
| 31st of March 2023 Next Fiscal Quarter End | View | |
| 1st of August 2023 Next Fiscal Year End | View | |
| 31st of December 2022 Last Quarter Report | View | |
| 30th of June 2022 Last Financial Announcement | View |
Build Portfolio with Cardiovascular Systems
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |